Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Antiplatelet Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT02974777
What this trial is testing

The IDEAL-PCI Extended Registry

Who this might be right for
Coronary ArteriosclerosesPlatelet Dysfunction Due to Drugs
Kaiser Franz Josef Hospital
Post-approval studies (Phase 4)Study completedNCT02601157
What this trial is testing

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Who this might be right for
Stable AnginaUnstable AnginaNon-ST Segment Elevation Myocardial Infarction
Seoul National University Hospital 2,173
Not applicableStudy completedNCT02918045
What this trial is testing

Dental Extractions in Patients Under Dual Antiplatelet Therapy

Who this might be right for
Blood Coagulation Disorders
University of Sao Paulo General Hospital 60
Very early researchStudy completedNCT03419325
What this trial is testing

A Genomic Approach for Clopidogrel in Caribbean Hispanics

Who this might be right for
Cardiovascular Disease (CVD)StrokeAcute Coronary Syndrome+3 more
University of Puerto Rico 150
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableLooking for participantsNCT07479056
What this trial is testing

Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndromes (ACS)Coronary Artery Disease (CAD)
SUK MIN SEO 400
Not applicableStudy completedNCT05476081
What this trial is testing

A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA

Who this might be right for
Ischemic StrokeTIA
University of L'Aquila 2,239
Testing effectiveness (Phase 2)UnknownNCT02495012
What this trial is testing

Anfibatide Treatment in STEMI Patients

Who this might be right for
ST Segment Elevation Myocardial Infarction
Lee's Pharmaceutical Limited 240
Not applicableUnknownNCT05122741
What this trial is testing

Modulation of Fibrosis-inducing Pathways in Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionMyocardial FibrosisMyocardial Remodeling, Ventricular
University of Messina 50
Post-approval studies (Phase 4)UnknownNCT02030054
What this trial is testing

Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 150
Post-approval studies (Phase 4)UnknownNCT01648829
What this trial is testing

PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07684742
What this trial is testing

Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromesSTEMINSTEMI+1 more
Gyeongsang National University Hospital 1,900
Not applicableUnknownNCT01701453
What this trial is testing

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)

Who this might be right for
Acute Coronary Syndrome
Samsung Medical Center 2,712
Not applicableStudy completedNCT06665919
What this trial is testing

The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models

Who this might be right for
Coronary Artery DiseaseClopidogrel ResistanceCoronary Thrombosis+5 more
Vistamedi Ltd. 283
Post-approval studies (Phase 4)Study completedNCT03581409
What this trial is testing

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

Who this might be right for
Aneurysm, CerebralEndovascular Procedures
Seoul National University Hospital 198
Large-scale testing (Phase 3)WithdrawnNCT02433587
What this trial is testing

Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization

Who this might be right for
Peripheral Arterial DiseaseEndovascular Procedures
University Hospitals Cleveland Medical Center
Not applicableStudy completedNCT00413309
What this trial is testing

Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Who this might be right for
Acute Coronary Syndrome
Brigham and Women's Hospital 30
Post-approval studies (Phase 4)Looking for participantsNCT06588595
What this trial is testing

The Switching Antiplatelet-9 (SWAP-9) Study

Who this might be right for
Coronary Arterial Disease (CAD)
University of Florida 90
Post-approval studies (Phase 4)UnknownNCT04407312
What this trial is testing

Cilostazol and Endothelial Progenitor Cell

Who this might be right for
Myocardial Infarction, Acute
Gyeongsang National University Hospital 60
Post-approval studies (Phase 4)Looking for participantsNCT07507500
What this trial is testing

Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

Who this might be right for
Myocardial Infarction (MI)
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 8,100
Next Page